Clinical trials
Terminated Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spectrum Pharmaceuticals, Inc | 3 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Abnoba Gmbh | 1 |
| Altor BioScience | 1 |
| Anchiano Therapeutics Israel Ltd. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Baylor College of Medicine | 1 |
| Bristol-Myers Squibb | 1 |
| Ferring Pharmaceuticals | 1 |
| Fidia Farmaceutici s.p.a. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 23 |
| Urinary Bladder Neoplasms | 17 |
| Carcinoma, Transitional Cell | 5 |
| Carcinoma in Situ | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 2 |
| Urinary Bladder Diseases | 2 |
| Urologic Diseases | 2 |
| Urologic Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.